Subcommittee on Neurological Disease committee  . Painless. Life-giving. It gave me back what I lost, and I can't thank them enough for that. I really can't. They're my heroes. I think you should let them be heroes for everybody else. My CCSVI was treated with a balloon angioplasty, a procedure that's done every day of the week

Subcommittee on Neurological Disease committee   started doing them without being trained by Zamboni, and some people with MS had negative studies. We thought that not everybody with MS was going to have CCSVI. I don't know if everybody with MS has CCSVI or not, but when we restudied the patients we had initially done prior to our

Subcommittee on Neurological Disease committee  Thank you. Do you have any ethical dilemma in deciding to treat MS patients with CCSVI?

Subcommittee on Neurological Disease committee  I would answer that in a different way. I think I have an ethical dilemma as a physician not to treat people with CCSVI. I think there is good anecdotal evidence to suggest that people with CCSVI do well with treatment. Again, as a vascular surgeon I do not treat MS; I treat

Subcommittee on Neurological Disease committee  During your presentation, you told us that, in your opinion, the only thing left to do was to sub-categorize the CCSVI patients. Could you expand a little more on that? In your view, what needs to be done and how long could a surgery like that take? Finally, why is it important

Subcommittee on Neurological Disease committee  Thank you. I think you need to do the ultrasound imaging that Sandy has talked about, but you need to do the MR imagining as well. We have discovered that there are many different sources for CCSVI, and not just narrowed vessels. Sometimes there are bad valves, and sometimes

Subcommittee on Neurological Disease committee   the scientific goal, which is actually generating the science on it, determining who should be treated, and so on, as you collect the data. At the same time, you can treat people with significant disease now. If they have significant CCSVIs demonstrated on an MRV and on a duplex scan

Multiple Sclerosis   the world, we are getting closer to finding better treatments for MS and hopefully a cure. Scientists are intrigued by the potential links between CCSVI and multiple sclerosis. CIHR welcomes and encourages funding applications from researchers wanting to study this new treatment. We

Multiple Sclerosis   is with respect to why would we not put a process in place to ensure that everyone who may have CCSVI, first has the opportunity to be diagnosed. If they are diagnosed with CCSVI, why not treat it? They should not be discriminated against having this treatment because they have MS. Why

Multiple Sclerosis   and controlled studies are required to prove a better understanding of this particular result. The MS societies, both in Canada and in the United States, have called the early findings surrounding CCSVI “exciting and intriguing” but have said “more research is required to firmly establish

Multiple Sclerosis  Madam Chair, the Sherwood Park MS Community Group in my riding is the largest MS group in the country. On their behalf, I would like to ask the minister how CIHR is mobilizing the research community around CCSVI and MS?

Multiple Sclerosis  Madam Chair, the MS Society made an announcement on June 11 to support further research. The MS Society of Canada and the MS Society in the United States say the following: These new studies are necessary because we don’t yet know whether, or if so how, CCSVI contributes to MS

Multiple Sclerosis  Madam Chair, the minister herself has mentioned that what is occurring is very promising, but I want to ask whether it is not correct to treat MS and the CCSVI in different functions. Where it indicates there are restrictions in a vein, why should people not have the treatment

Multiple Sclerosis  Madam Chair, MS societies in Canada and the United States have called their early findings surrounding CCSVI exciting, but they have also said they want more research. We will continue to work with them in terms of providing support to see if this new method is effective or not.

Multiple Sclerosis   cerebrospinal venous insufficiency, CCSVI. I have personally called, emailed, or met 1,000 MS patients and their families across this country. I have been touched by each and every one, and I am proud to know these extraordinary people. I understand that this next four hours may determine